Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks With Monster Returns. Hims & Hers saw its share prices jump by 48.3 percent week-on-week as investors positioned portfolios ahead of the ...
Eli Lilly (LLY) is in advanced negotiations to acquire privately held biotech Kelonia Therapeutics in a deal valued at more ...
Notably, investors poured funds into industries with promising growth prospects, namely semiconductor and quantum computing, ...
India’s pharmaceutical companies are in an intense race to create cheaper generic versions of weight-loss drugs after the ...
For many years, scientists and doctors have focused on one main idea when it comes to modern weight loss medicines. They ...
Weight-loss drug developer Kailera Therapeutics' shares surged 62.5% in their Nasdaq debut on Friday after closing a $625 ...
As many of us know, keeping weight in check can be hard. National data reflect that reality. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact on ...
On April 15, 2026, JPMorgan initiated coverage of ResMed Inc. (NYSE:RMD) with an “Overweight” rating and an A$37.60 price ...
According to Dr. Laudenslager and Hall, taking GLP1-s can indeed decrease bone density for some people. But that’s likely due ...
Two years ago, Sue Prentiss got a sobering reality check at her doctor’s office. The news was blunt: She qualified for bariatric surgery, a procedure for patients whose weight poses life-threatening ...
A new study has identified a naturally occurring peptide linked to weight loss. Afraid of taking Ozempic? There’s a way to do ...
A booming online marketplace exists for alternatives to popular weight-loss medications. But these drugs can be risky.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results